Xing et al. found that EZH2 represses EBF1 expression by increasing promoter H3K27me, which subsequently activates the expression of TERT33, while another study showed that EZH2 may promote cancer via the downregulation of PTEN34. The gene discussed is EZH2; the disease is cancer.